高级检索
    王深明, 殷恒讳, 李学瑞. 曲妥珠单抗每三周方案联合紫杉醇治疗HER-2阳性转移性乳腺癌的药代动力学、安全性及有效性研究[J]. 循证医学, 2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
    引用本文: 王深明, 殷恒讳, 李学瑞. 曲妥珠单抗每三周方案联合紫杉醇治疗HER-2阳性转移性乳腺癌的药代动力学、安全性及有效性研究[J]. 循证医学, 2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
    shu
    WANG Shen-ming, YIN Heng-hui, LI Xue-rui. Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
    Citation: WANG Shen-ming, YIN Heng-hui, LI Xue-rui. Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
    shu

    曲妥珠单抗每三周方案联合紫杉醇治疗HER-2阳性转移性乳腺癌的药代动力学、安全性及有效性研究

    Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回